Skip to main content

Table 2 Association between waiting time and the change in BPI from baseline to the 6-month follow-up, for the overall sample and by main rheumatic condition

From: The association between waiting time and multidisciplinary pain treatment outcomes in patients with rheumatic conditions

 

BPI at baseline, Mean (SD)

BPI at 6 months, Mean (SD)

GEE models

Unadj.

p value a

Unadj. change from baseline to 6 months, EMM (95% CI)

Adj. p value a,b

Adj. change from baseline to 6 months, EMM b (95% CI)

Overall sample (n)

3228

1946

< 0.001

 

< 0.001

 

 Total

5.97 (2.13)

5.20 (2.48)

    

 <  2 months

5.77 (2.24)

4.61 (2.65)

 

−1.16 [− 1.45, − 0.87]

 

− 1.12 [− 1.42, − 0.81]

 2–6 months

6.12 (2.10)

5.38 (2.39)

 

− 0.70 [− 0.91, − 0.48]

 

− 0.70 [− 0.93, − 0.48]

 > 6 months

6.00 (2.07)

5.49 (2.34)

 

− 0.51 [− 0.69, − 0.32]

 

− 0.47 [− 0.66, − 0.28]

Osteoarthritis (n)

668

394

    

 Total

5.71 (2.19)

4.87 (2.59)

0.004

 

0.033

 

 <  2 months

5.73 (2.25)

4.33 (2.68)

 

− 1.40 [− 2.12, − 0.68]

 

− 1.24 [− 2.02, − 0.46]

 2–6 months

5.82 (2.20)

5.05 (2.56)

 

−0.63 [− 1.15, − 0.11]

 

− 0.66 [− 1.19, − 0.12]

 > 6 months

5.59 (2.13)

5.15 (2.50)

 

− 0.40 [− 0.85, 0.042]

 

−0.40 [− 0.85, 0.05]

Fibromyalgia (n)

677

359

    

 Total

6.13 (2.11)

5.52 (2.40)

0.003

 

0.002

 

 < 2 months

6.21 (2.05)

4.97 (2.44)

 

− 1.28 [− 1.98, −0.57]

 

− 1.30 [− 2.05, − 0.55]

 2–6 months

6.02 (2.20)

5.31 (2.53)

 

−0.72 [− 1.20, − 0.24]

 

−0.76 [− 1.27, − 0.24]

 > 6 months

6.20 (2.06)

6.02 (2.18)

 

− 0.35 [− 0.71, − 0.004]

 

−0.32 [− 0.65, 0.02]

  1. BPI Brief pain inventory (average score on the 0–10 interference items), SD standard deviation, GEE generalized estimating equations, EMM estimated marginal means, 95% CI 95% confidence interval
  2. a Time X group effect p value
  3. b Adjusted for age, sex, pain duration, number of comorbidities and income